Join us for an evening of panel discussion and networking.
The Chicago Booth Angels Network of London will be hosting a Biotech-focused investment event on 12 May 2022 featuring VC partners in the field. The panellists will discuss the investment landscape in Biotech in 2022 with a specific focus on early stage investing. The panel discussion will be followed by 3-4 pitches.
Presenting start-ups will be selected by the panel and the Chicago Booth Angels Network team and will be announced closer to the date.
£25 for in-person attendance, no charge for online attendance.
6:30 PM-7:00 PM: Welcome and Reception
7:00 PM-8:00 PM: Program
8:00 PM-9:00 PM: Networking Reception (In-Person)
Sunil Shah (Speaker)
CEO, Co-Founder, o2h ventures, o2h group
Sunil is a serial entrepreneur, having begun a career in the Life Sciences team at PA Consulting group followed by co-founding two companies in the information technology and life sciences sector. The second of these companies, Oxygen Healthcare Ltd was acquired by Piramal Enterprises Ltd (BSE: PEL). Sunil co-founded o2h ventures which involves discovery services / collaborations, seeding drug discovery, academic in-licensing and biotechnology incubation. Sunil has a degree in Biochemistry and an MBA from Cambridge University.
Jess McCreadie (Speaker)
Principal, Octopus Ventures
Prior to joining Octopus Ventures in June 2021, Jess led the health tech investing team at Legal & General, supporting leading health innovations. She invested balance sheet capital into early-stage health tech businesses and supported scale up via board representation in her portfolio. Earlier in her career Jess invested into and was a banker in a range of alternative asset classes including renewable energy, real estate, and Venture Capital Funds. Jess has a passion for sustainability and delivering social impact alongside economic value.